Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers halt the Mosaico study after an experimental vaccine was found to be safe but not effective against HIV.
Conspiracy theorists ignore Magic Johnson’s own words: “I am certain that I was infected by having unprotected sex with a woman.”
Experimental vaccine aims to train B cells to produce broadly neutralizing antibodies that target HIV.
Fauci led the U.S. HIV research effort for nearly 40 years before becoming the nation’s leading COVID-19 medical advisor.
What have we learned from the COVID-19 pandemic, and what’s the future of HIV vaccine research? Find out this #HVAD2022.
The HVTN 302 trial is evaluating experimental vaccines that deliver stabilized HIV spike proteins.
An expanded HIV Vaccine Trials Network Faith Initiative aims to reach Black, Latino and Indigenous communities of faith. [VIDEO]
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
None of the available coronavirus vaccines have been linked to increased risk of HIV acquisition or disease progression.
More HIV prevention misinformation is coming from the right.
The vaccine regimen tested in the Imbokodo trial was similar to the J&J COVID-19 vaccine, but an mRNA approach may hold more promise.
The experimental vaccines use the same technology as the highly effective Moderna COVID-19 shot.
People who received a canarypox vector vaccine regimen were no less likely than placebo recipients to acquire HIV.
AVAC’s theme for HVAD 2021 is “HIV Vaccine Research: Building on Lessons from COVID.”
Abbott researchers found a high proportion of elite HIV controllers in the Democratic Republic of Congo, which could lead to cure insights.
Social media posts that make misleading comparisons undermine the science behind the COVID-19 vaccine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.